Lexicon Pharmaceuticals, Inc. (LXRX)
NASDAQ: LXRX · Real-Time Price · USD
2.320
-0.020 (-0.85%)
At close: Aug 14, 2026, 4:00 PM EDT
2.348
+0.028 (1.22%)
After-hours: Aug 14, 2026, 7:34 PM EDT

Lexicon Pharmaceuticals Revenue

Lexicon Pharmaceuticals had revenue of $692.00K in the quarter ending June 30, 2026, a decrease of -97.60%. This brings the company's revenue in the last twelve months to $41.47M, down -29.03% year-over-year. In the year 2025, Lexicon Pharmaceuticals had annual revenue of $49.80M with 60.24% growth.

Revenue (ttm)
$41.47M
Revenue Growth
-29.03%
P/S Ratio
24.89
Revenue / Employee
$511,963
Employees
81
Market Cap
1.03B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202549.80M18.72M60.24%
Dec 31, 202431.08M29.88M2,481.48%
Dec 31, 20231.20M1.07M766.19%
Dec 31, 2022139.00K-159.00K-53.36%
Dec 31, 2021298.00K-23.70M-98.76%
Dec 31, 202024.00M-298.08M-92.55%
Dec 31, 2019322.07M258.86M409.54%
Dec 31, 201863.21M-28.48M-31.06%
Dec 31, 201791.69M12.43M15.69%
Dec 31, 201679.26M-50.76M-39.04%
Dec 31, 2015130.01M107.16M468.89%
Dec 31, 201422.85M20.63M928.53%
Dec 31, 20132.22M1.13M104.04%
Dec 31, 20121.09M-760.00K-41.10%
Dec 31, 20111.85M-3.06M-62.33%
Dec 31, 20104.91M-5.79M-54.13%
Dec 31, 200910.70M-21.62M-66.89%
Dec 31, 200832.32M-17.80M-35.51%
Dec 31, 200750.12M-22.68M-31.15%
Dec 31, 200672.80M-2.88M-3.81%
Dec 31, 200575.68M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Ardelyx450.89M
Geron204.56M
Apnimed120.15M
Wave Life Sciences65.37M
Janux Therapeutics24.00M
Inventiva7.94M
Odyssey Therapeutics99.00K
Avalo Therapeutics59.00K
Revenue Rankings